Emerging Neuromodulation Techniques: Treatment of SUDs with TMS and Focused Ultrasound

Saturday, April 26, 2025

10:30 AM – 11:45 AM

Presenter(s)

Kira V. Panzer, MD

Psychiatry Resident
University of Virginia
Charlottesville, Virginia
JG

Jamie Gentry, DO

Addiction Medicine Fellow
UVA Medical Center
Charlottesville, Virginia
JL

Joseph A. Legan, MD

Assistant Professor
University of Virginia
Charlottesville, Virginia
NA

Nassima Ait-Daoud, MD

Professor
UVA
Charlottesville, Virginia

Neuromodulation techniques, particularly Transcranial Magnetic Stimulation (TMS), offer promising avenues for improving outcomes in substance use disorder (SUD) treatment by targeting neural circuits involved in addiction. This Focus Session will provide an overview of the latest developments in neuromodulation for SUD, focusing on the use of TMS for smoking cessation, as well as new applications for stimulant, opioid, and alcohol use disorders.

Learning Objectives:

Learners will be able to:

Articulate how the neurobiology of substance use disorders (SUDs) informs neuromodulation treatment options.
Describe the evolution of neuromodulation techniques as treatment for SUD, with particular emphasis on transcranial magnetic stimulation (TMS) and its expanding role across multiple substances.
Recognize how Deep TMS functions as an FDA-approved treatment for smoking cessation and explore future directions in SUD treatment, such as combining neuromodulation with other therapies to optimize treatment outcomes.

Disclosure(s):

Kira V. Panzer, MD: No financial relationships to disclose

Jamie Gentry, DO: No financial relationships to disclose

Joseph A. Legan, MD: No financial relationships to disclose

Nassima Ait-Daoud, MD: No financial relationships to disclose